Business Context and Reporting Period
This Form 8-K reports the results of the annual meeting of stockholders for Novavax, Inc., held on June 9, 2016. The record date for voting eligibility was April 13, 2016. As of the record date, there were 270,778,671 shares outstanding, with 225,645,874 shares represented at the meeting, constituting a quorum.
Key Financial Metrics
This filing is a current report regarding corporate governance and stockholder votes. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent Form 10-K or 10-Q for financial performance details.
Material Changes and Voting Results
Stockholders voted on four proposals with the following outcomes:
- Proposal 1 (Election of Directors): Stockholders elected three Class III nominees to serve until the 2019 Annual Meeting:
- Gail K. Boudreaux: 142,882,447 For; 726,529 Withheld.
- Michael A. McManus, Jr., J.D.: 135,802,228 For; 7,806,748 Withheld.
- James F. Young, Ph.D.: 142,674,828 For; 934,148 Withheld.
- Proposal 2 (Stock Incentive Plan): Approved the Amended and Restated 2015 Stock Incentive Plan, increasing available shares by 6,000,000.
- For: 135,133,271 | Against: 8,127,228 | Abstaining: 348,387.
- Proposal 3 (Employee Stock Purchase Plan): Approved the Amended and Restated 2013 Employee Stock Purchase Plan, increasing available shares by 1,000,000.
- For: 123,562,234 | Against: 19,732,299 | Abstaining: 314,353.
- Proposal 4 (Auditor Ratification): Ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2016.
- For: 217,989,349 | Against: 1,005,910 | Abstaining: 6,650,615.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risk factors, or contingencies. It is strictly a report of the stockholder vote results.
Important Facts for Investors to Verify
- Confirmation that the 6,000,000 share increase in the 2015 Stock Incentive Plan and the 1,000,000 share increase in the 2013 Employee Stock Purchase Plan are now effective.
- The tenure of the newly elected Class III directors (Gail K. Boudreaux, Michael A. McManus, Jr., and James F. Young) extending through the 2019 Annual Meeting.
- The ratification of Ernst & Young LLP as the auditor for the fiscal year ending December 31, 2016.
- Review of the company's latest 10-K or 10-Q for financial health, as this 8-K contains no financial metrics.